Correlation Between Iteos Therapeutics and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Iteos Therapeutics and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Iteos Therapeutics and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Iteos Therapeutics and Tscan Therapeutics, you can compare the effects of market volatilities on Iteos Therapeutics and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Iteos Therapeutics with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Iteos Therapeutics and Tscan Therapeutics.
Diversification Opportunities for Iteos Therapeutics and Tscan Therapeutics
0.59 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Iteos and Tscan is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Iteos Therapeutics and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Iteos Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Iteos Therapeutics are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Iteos Therapeutics i.e., Iteos Therapeutics and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Iteos Therapeutics and Tscan Therapeutics
Given the investment horizon of 90 days Iteos Therapeutics is expected to under-perform the Tscan Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Iteos Therapeutics is 2.02 times less risky than Tscan Therapeutics. The stock trades about -0.13 of its potential returns per unit of risk. The Tscan Therapeutics is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 489.00 in Tscan Therapeutics on August 28, 2024 and sell it today you would lose (37.00) from holding Tscan Therapeutics or give up 7.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
Iteos Therapeutics vs. Tscan Therapeutics
Performance |
| Timeline |
| Iteos Therapeutics |
| Tscan Therapeutics |
Iteos Therapeutics and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Iteos Therapeutics and Tscan Therapeutics
The main advantage of trading using opposite Iteos Therapeutics and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Iteos Therapeutics position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| Iteos Therapeutics vs. Annexon | Iteos Therapeutics vs. Monte Rosa Therapeutics | Iteos Therapeutics vs. Design Therapeutics | Iteos Therapeutics vs. Erasca Inc |
| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges |